PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF

The present invention relates to a pyrrole fused ring derivative or a stereoisomer thereof, a pharmaceutical composition thereof, and the pharmaceutical use thereof; and specifically relates to a pyrrole fused ring derivative as shown in general formula (I), or a stereoisomer, a solvate, a metabolit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SUN, Yi, YUAN, Yonghai, WEI, Yonggang, XU, Xuezhen, JIA, Zhilong
Format: Patent
Sprache:chi ; eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SUN, Yi
YUAN, Yonghai
WEI, Yonggang
XU, Xuezhen
JIA, Zhilong
description The present invention relates to a pyrrole fused ring derivative or a stereoisomer thereof, a pharmaceutical composition thereof, and the pharmaceutical use thereof; and specifically relates to a pyrrole fused ring derivative as shown in general formula (I), or a stereoisomer, a solvate, a metabolite, a prodrug, a pharmaceutically acceptable salt or a co-crystal thereof, a pharmaceutical composition comprising same, and the use of the compound or composition of the present application in the preparation of a drug for treating cancer. The compound of the present invention has therapeutic effects on Polθ-mediated cancers or tumors, and also has a good selectivity and low side effects. La présente invention concerne un dérivé à cycle condensé de pyrrole ou un stéréoisomère de celui-ci, une composition pharmaceutique de celui-ci, et son utilisation pharmaceutique; et en particulier un dérivé à cycle condensé de pyrrole tel que représenté dans la formule générale (I), ou un stéréoisomère, un solvate, un métabolite
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024109688A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024109688A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024109688A13</originalsourceid><addsrcrecordid>eNrjZLAJiAwK8vdxVXALDXZ1UQjy9HNXcHEN8gxzDPEMc1Vw9HNRCPBwDPJ1dHYNDfF0dvRRAKpTCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiaGBpZmFhaOhsbEqQIAt1Iqmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF</title><source>esp@cenet</source><creator>SUN, Yi ; YUAN, Yonghai ; WEI, Yonggang ; XU, Xuezhen ; JIA, Zhilong</creator><creatorcontrib>SUN, Yi ; YUAN, Yonghai ; WEI, Yonggang ; XU, Xuezhen ; JIA, Zhilong</creatorcontrib><description>The present invention relates to a pyrrole fused ring derivative or a stereoisomer thereof, a pharmaceutical composition thereof, and the pharmaceutical use thereof; and specifically relates to a pyrrole fused ring derivative as shown in general formula (I), or a stereoisomer, a solvate, a metabolite, a prodrug, a pharmaceutically acceptable salt or a co-crystal thereof, a pharmaceutical composition comprising same, and the use of the compound or composition of the present application in the preparation of a drug for treating cancer. The compound of the present invention has therapeutic effects on Polθ-mediated cancers or tumors, and also has a good selectivity and low side effects. La présente invention concerne un dérivé à cycle condensé de pyrrole ou un stéréoisomère de celui-ci, une composition pharmaceutique de celui-ci, et son utilisation pharmaceutique; et en particulier un dérivé à cycle condensé de pyrrole tel que représenté dans la formule générale (I), ou un stéréoisomère, un solvate, un métabolite</description><language>chi ; eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240530&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024109688A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240530&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024109688A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUN, Yi</creatorcontrib><creatorcontrib>YUAN, Yonghai</creatorcontrib><creatorcontrib>WEI, Yonggang</creatorcontrib><creatorcontrib>XU, Xuezhen</creatorcontrib><creatorcontrib>JIA, Zhilong</creatorcontrib><title>PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF</title><description>The present invention relates to a pyrrole fused ring derivative or a stereoisomer thereof, a pharmaceutical composition thereof, and the pharmaceutical use thereof; and specifically relates to a pyrrole fused ring derivative as shown in general formula (I), or a stereoisomer, a solvate, a metabolite, a prodrug, a pharmaceutically acceptable salt or a co-crystal thereof, a pharmaceutical composition comprising same, and the use of the compound or composition of the present application in the preparation of a drug for treating cancer. The compound of the present invention has therapeutic effects on Polθ-mediated cancers or tumors, and also has a good selectivity and low side effects. La présente invention concerne un dérivé à cycle condensé de pyrrole ou un stéréoisomère de celui-ci, une composition pharmaceutique de celui-ci, et son utilisation pharmaceutique; et en particulier un dérivé à cycle condensé de pyrrole tel que représenté dans la formule générale (I), ou un stéréoisomère, un solvate, un métabolite</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJiAwK8vdxVXALDXZ1UQjy9HNXcHEN8gxzDPEMc1Vw9HNRCPBwDPJ1dHYNDfF0dvRRAKpTCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiaGBpZmFhaOhsbEqQIAt1Iqmg</recordid><startdate>20240530</startdate><enddate>20240530</enddate><creator>SUN, Yi</creator><creator>YUAN, Yonghai</creator><creator>WEI, Yonggang</creator><creator>XU, Xuezhen</creator><creator>JIA, Zhilong</creator><scope>EVB</scope></search><sort><creationdate>20240530</creationdate><title>PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF</title><author>SUN, Yi ; YUAN, Yonghai ; WEI, Yonggang ; XU, Xuezhen ; JIA, Zhilong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024109688A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SUN, Yi</creatorcontrib><creatorcontrib>YUAN, Yonghai</creatorcontrib><creatorcontrib>WEI, Yonggang</creatorcontrib><creatorcontrib>XU, Xuezhen</creatorcontrib><creatorcontrib>JIA, Zhilong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUN, Yi</au><au>YUAN, Yonghai</au><au>WEI, Yonggang</au><au>XU, Xuezhen</au><au>JIA, Zhilong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF</title><date>2024-05-30</date><risdate>2024</risdate><abstract>The present invention relates to a pyrrole fused ring derivative or a stereoisomer thereof, a pharmaceutical composition thereof, and the pharmaceutical use thereof; and specifically relates to a pyrrole fused ring derivative as shown in general formula (I), or a stereoisomer, a solvate, a metabolite, a prodrug, a pharmaceutically acceptable salt or a co-crystal thereof, a pharmaceutical composition comprising same, and the use of the compound or composition of the present application in the preparation of a drug for treating cancer. The compound of the present invention has therapeutic effects on Polθ-mediated cancers or tumors, and also has a good selectivity and low side effects. La présente invention concerne un dérivé à cycle condensé de pyrrole ou un stéréoisomère de celui-ci, une composition pharmaceutique de celui-ci, et son utilisation pharmaceutique; et en particulier un dérivé à cycle condensé de pyrrole tel que représenté dans la formule générale (I), ou un stéréoisomère, un solvate, un métabolite</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng ; fre
recordid cdi_epo_espacenet_WO2024109688A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A37%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUN,%20Yi&rft.date=2024-05-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024109688A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true